LYN activity has been reported to promote the epithelial-mesenchymal transition through Vav-Rac1-PAK1-mediated control of SNAI protein localisation and stability in multiple cancer types, including breast cancer (Thaper et al., 2017). This evidence concerns the gene PAK1 and breast cancer.